Nivalis Therapeutics Reports Financial Results for the Second Quarter 2015
August 03, 2015 16:10 ET
|
Nivalis Therapeutics, Inc.
– Phase 1b Clinical Study Completes Enrollment –
– No Safety Signal Reported from Safety Monitoring Committee –
– Phase 2 Initiation on Schedule for Q4...
Nivalis Therapeutics Announces Closing of Its Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
June 23, 2015 08:02 ET
|
Nivalis Therapeutics, Inc.
BOULDER, Colo., June 23, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today the...
Nivalis Therapeutics Announces Pricing of Its Initial Public Offering
June 16, 2015 21:52 ET
|
Nivalis Therapeutics, Inc.
BOULDER, Colo., June 16, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc., (Nasdaq:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, announced today...